BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9596698)

  • 1. Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patients.
    Johnson BJ; Estrada I; Shen Z; Ress S; Willcox P; Colston MJ; Kaplan G
    Infect Immun; 1998 Jun; 66(6):2426-33. PubMed ID: 9596698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy.
    Johnson BJ; Ress SR; Willcox P; Pati BP; Lorgat F; Stead P; Saha R; Lukey P; Laochumroonvorapong P; Corral L
    Cytokines Mol Ther; 1995 Sep; 1(3):185-96. PubMed ID: 9384675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis.
    Johnson B; Bekker LG; Ress S; Kaplan G
    Novartis Found Symp; 1998; 217():99-106; discussion 106-11. PubMed ID: 9949803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    Zhang R; Xi X; Wang C; Pan Y; Ge C; Zhang L; Zhang S; Liu H
    PLoS One; 2018; 13(7):e0201025. PubMed ID: 30024982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo.
    Johnson BJ; Bekker LG; Rickman R; Brown S; Lesser M; Ress S; Willcox P; Steyn L; Kaplan G
    Tuber Lung Dis; 1997; 78(3-4):195-203. PubMed ID: 9713652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis.
    Torres M; Herrera T; Villareal H; Rich EA; Sada E
    Infect Immun; 1998 Jan; 66(1):176-80. PubMed ID: 9423855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12.
    Marchant A; Amedei A; Azzurri A; Vekemans J; Benagiano M; Tamburini C; Lienhardt C; Corrah T; McAdam KP; Romagnani S; D'Elios MM; Del Prete G
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):187-94. PubMed ID: 11159053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring.
    Essone PN; Kalsdorf B; Chegou NN; Loxton AG; Kriel M; Preyer R; Ernst M; Walzl G; Lange C
    Respiration; 2014; 88(3):251-61. PubMed ID: 25171202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis.
    Song CH; Kim HJ; Park JK; Lim JH; Kim UO; Kim JS; Paik TH; Kim KJ; Suhr JW; Jo EK
    Infect Immun; 2000 Aug; 68(8):4477-84. PubMed ID: 10899845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17
    Basile JI; Kviatcovsky D; Romero MM; Balboa L; Monteserin J; Ritacco V; Lopez B; Sabio y García C; García A; Vescovo M; Montaner PG; Palmero D; Del Carmen Sasiain M; de la Barrera S
    Clin Exp Immunol; 2017 Jan; 187(1):160-173. PubMed ID: 27681197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ and interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis.
    Nunnari G; Pinzone MR; Vancheri C; Palermo F; Cacopardo B
    Clin Invest Med; 2013 Apr; 36(2):E64-71. PubMed ID: 23544607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.
    Kim HJ; Chung DH; Kim MJ; Jang JH; Kim YW; Han SK; Shim YS; Yim JJ
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1071-6. PubMed ID: 18713507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.
    Riganò R; Profumo E; Buttari B; Teggi A; Siracusano A
    Clin Exp Immunol; 1999 Oct; 118(1):95-101. PubMed ID: 10540165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy.
    Al-Attiyah R; Mustafa AS; Abal AT; Madi NM; Andersen P
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):249-56. PubMed ID: 14522460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production.
    Hirsch CS; Hussain R; Toossi Z; Dawood G; Shahid F; Ellner JJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3193-8. PubMed ID: 8622912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.
    Lee JS; Song CH; Kim CH; Kong SJ; Shon MH; Kim HJ; Park JK; Paik TH; Jo EK
    Clin Exp Immunol; 2002 Jun; 128(3):516-24. PubMed ID: 12067307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin.
    Moura EP; Toledo VP; Oliveira MH; Spíndola-de-Miranda S; Andrade HM; Guimarães TM
    Mem Inst Oswaldo Cruz; 2004 May; 99(3):283-7. PubMed ID: 15273801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
    Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
    Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis.
    Jo EK; Kim HJ; Lim JH; Min D; Song Y; Song CH; Paik TH; Suhr JW; Park JK
    Scand J Immunol; 2000 Feb; 51(2):209-17. PubMed ID: 10652166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.